Depression? It's the Disease NOT the Drug
Kircik, L.H.
Journal of Drugs in Dermatology Jdd 17(8): S28
2018
ISSN/ISBN: 1545-9616 PMID: 30124736 Document Number: 16509
Research into the immunopathological mechanisms of plaque psoriasis has produced increasingly targeted biologic therapies. The specificity of these agents allows for high rates of efficacy and decreased adverse events, most notably reduced immune system suppression. In recent years, the recognition of interleukin (IL)-17 as an important component in the pathogenesis of psoriasis has led to the development of a new class of biologics.
Document emailed within 1 workday
